Syddall HE, Westbury LD, Cooper C, Sayer AA
J Am Med Dir Assoc 2014; Dec 15 [Epub ahead of print]
Publication date: December 15, 2014
Walking speed is central to emerging consensus definitions of sarcopenia and frailty; it is also a major predictor of future health outcomes in its own right. However, measurement is not always feasible in clinical settings.
Syddall and co-authors hypothesized that self-reported walking speed might be a good marker of objectively measured walking speed. They investigated the relationship between self-reported and measured walking speed and their associations with clinical characteristics and mortality using data from 730 men and 999 women, aged 61 to 73 years, who participated in the Hertfordshire Cohort Study. Walking speed was measured over 3 meters. Participants rated their walking speed as “unable to walk,” “very slow,” “stroll at an easy pace,” “normal speed,” “fairly brisk,” or “fast.”
Self-reported walking speed was strongly associated with measured walking speed among men and women. Average walking speeds ranged from 0.78 m/s (95% CI, 0.73‒0.83) among men with “very slow” self-reported walking speed to 0.98 m/s (95% CI, 0.93‒1.03) among “fast” walkers. Corresponding figures for women were 0.72 m/s (95% CI, 0.68‒0.75) and 1.01 m/s (95% CI, 0.98‒1.05).
Self-reported and measured walking speeds were similarly associated with clinical characteristics and mortality; among men and women, slower self-reported and measured walking speeds were associated (P < 0.05) with increased likelihood of poor physical function, having more systems medicated and increased mortality risk.
This study demonstrates that self-reported walking speed is a good marker of measured walking speed and could serve as a useful marker of physical performance in consensus definitions of sarcopenia and frailty when direct measurement of walking speed is not feasible.